Danaher Appoints Rainer M. Blair As President And CEO

Danaher Appoints Rainer M. Blair As President And CEO WASHINGTON, Sept. 1, 2020 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (“Danaher” or “the Company”) announced that the Company’s Board of Directors has implemented its previously disclosed succession plan and appointed Rainer M. Blair as President and Chief Executive Officer and a member of the Board of... Read more

Roche to launch SARS-CoV-2 Rapid Antigen Test in countries accepting CE mark, allowing fast triage decisions at point of care

Antigen test reliably and quickly triages people suspected of SARS-CoV-2, with results ready in 15 minutes, allowing informed treatment decisions Antigen test accurately screens individuals with known exposure to infected SARS-CoV-2 patients, providing fast answers regarding their infection status Affordable and small, instrument-free testing kit enables convenient use for healthcare professionals at different point of... Read more

Nikon introduces Clarify.ai for NIS-Elements, an artificial intelligence algorithm for removing blur from widefield microscope images

Sep 1, 2020 Nikon Instruments Inc. is pleased to announce the release of NIS-Elements Clarify.ai, a new addition to Nikon’s growing suite of artificial intelligence (AI) tools for microscopy. Clarify.ai uses artificial intelligence to automatically remove blur from widefield fluorescence microscope images. Clarify.ai utilizes new Nikon technologies executed on graphic processing units (GPUs) to leverage fast... Read more

Health Canada Licenses First Artificial Intelligence Algorithms Embedded On-Device to Prioritize Critical Chest X-ray Review

Critical Care Suite helps radiologists prioritize critical cases with a suspected pneumothorax – a type of collapsed lung – by immediately flagging critical cases to radiologists for triage, which could drastically cut the average review time from up to eight hours[1] Offers first-of-its-kind automated AI quality check features that detect acquisition errors, flagging images for... Read more

Roche receives FDA approval for first HIV-1/HIV-2 Qualitative Test on the cobas 6800/8800 Systems in the fight against HIV/AIDS

Detects, confirms and differentiates HIV-1 and HIV-2 infections providing clinicians with critical diagnostic data for personalised management of patients with HIV – from appropriate counseling on disease differences to targeted therapy Supports rapid molecular detection of acute HIV infection, which is critical in curbing further disease transmission Combines confirmatory HIV testing and HIV-1/HIV-2 differentiation into... Read more

| CDX Installation Profile

| CDX Installation Profile Skip to main content Drupal already installed To start over, you must empty your existing database and copy default.settings.php over settings.php. To upgrade an existing installation, proceed to the update script. View your existing site. http://www.genewsroom.com/feeds/healthcare.rss.xml Read more

Thermo Fisher Scientific Officially Opens New Site for Manufacturing COVID-19 Sample Collection Products

Thermo Fisher Scientific Officially Opens New Site for Manufacturing COVID-19 Sample Collection Products New facility in Lenexa, Kansas built in six weeks to rapidly expand production of viral transport media LENEXA, Kan., Aug. 28, 2020 /PRNewswire/ — Thermo Fisher Scientific Inc., the world leader in serving science, officially cut the ribbon on its new $40 million facility in... Read more

Shimadzu and HORIBA to Collaborate on Development and Sales of LC-Raman Analytical and Measuring InstrumentsTowards the Commercialization of Analytical and Measuring Instruments that Combine a High-Performance Liquid Chromatograph and a Raman Spectrometer

08/28/2020 |   Press Release Towards the Commercialization of Analytical and Measuring Instruments that Combine a High-Performance Liquid Chromatograph and a Raman Spectrometer On August 3rd, Shimadzu Corporation (President & CEO: Teruhisa Ueda, hereinafter Shimadzu) and HORIBA, Ltd. (President & COO: Masayuki Adachi, hereinafter HORIBA) concluded a basic agreement to commence collaboration on the development and sales of... Read more

Roche announces FDA approval of FoundationOne Liquid CDx, a comprehensive pan-tumour liquid biopsy test

FoundationOne Liquid CDx analyses more than 300 cancer-related genes and multiple genomic signatures to help inform treatment decisions for all solid tumour cancers Using a simple blood draw, the test allows more patients with advanced cancer to benefit from the insights of comprehensive genomic profiling, for example when a tissue biopsy is not possible or... Read more

Brooks to Participate in the Citi's 2020 Global Technology Virtual Conference

CHELMSFORD, Mass., Aug. 27, 2020 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq:BRKS) announced today that company management will participate in Citi’s 2020 Global Technology Virtual Conference on Wednesday, September 9, 2020 which includes a 45-minute webcast beginning at 9:50 a.m. ET.  The live webcast can be accessed through the Brooks investor relations website at www.brooks.investorroom.com/events. A replay... Read more